From Pathology to Materials Science and Engineering: Harnessing the Amyloid State for Biotechnological Applications
Lucas B Fallot1,2, Chandramouli Natarajan1, Carol A Anderson1,2
1Department of Chemical and Biological Science and Engineering, United States Military Academy, West Point, New York 10996, United States.
ACS Applied Materials & Interfaces
|November 10, 2025
Summary
Protein misfolding causes diseases like Alzheimer's. This review explores using amyloid structures for novel biotechnologies, from drug delivery to bioelectronics, offering societal benefits.
Area of Science:
- Biochemistry and Materials Science
- Biotechnology and Nanotechnology
Background:
- Protein misfolding and aggregation are central to over 60 diseases, including Alzheimer's and Parkinson's.
- Proteins transition from disordered monomers to ordered amyloid fibrils with extensive beta-sheet structures.
- Functional amyloids also play roles in physiological processes across organisms.
Purpose of the Study:
- To review the principles governing amyloid formation.
- To explore leveraging amyloid biophysical properties and templating abilities for biotechnological applications.
- To discuss the potential of amyloid-based materials in diverse fields.
Main Methods:
- Review of existing literature on amyloid formation and functional amyloids.
- Analysis of the biophysical properties and templating capabilities of amyloid structures.
- Identification and categorization of potential biotechnological applications.
Main Results:
- Amyloid formation involves a transition to highly ordered, fibrillar structures.
- Amyloids possess unique biophysical properties and templating abilities.
- Diverse applications include aerogels, hydrogels, drug delivery, tissue engineering, antimicrobials, catalysis, and bioelectronics.
Conclusions:
- Amyloid structures offer significant potential for developing novel biomaterials.
- Successful implementation of amyloid-based biotechnologies requires addressing current challenges.
- Future research can unlock widespread societal benefits from amyloid applications.
Related Concept Videos
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Amyloid Fibrils
6.3K
6.3K


